CIK: 1581992 - Address: C/o Intellia Therapeutics, Inc., 40 Erie Street; Suite 130, Cambridge, MA 02139
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/5/24 16:49
1/3/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard GlennMAOEVP,CFOS-15829.460-5-1241D
1/3/24 17:28
1/1/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard GlennMAOEVP,CFOM.d00.0003746D
1/6/23 17:23
1/4/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard GlennMAOEVP,CFOS-9037.210-2-1415D
1/4/23 20:29
1/1/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard GlennMAOEVP,CFOM.d00.00032118D
3/3/22 19:38
1/1/22
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard GlennMAOEVP,CFOM.d00.00032615D
3/3/22 19:38
1/1/22
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard GlennMAOEVP,CFOS.d-114112.240-1-615D
9/9/21 17:38
9/7/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard GlennMAOEVP,CFOM.d5114.58030D
9/9/21 17:38
9/7/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard GlennMAOEVP,CFOS.d-627180.120-3-1000D
9/1/21 19:30
8/30/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard GlennMAOEVP,CFOM.dm57018.990300D
9/1/21 19:30
8/30/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGoddard GlennMAOEVP,CFOS.dm-4,784159.450-30-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact